Related Experiment Video
Updated: Jul 13, 2026
07:13
Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity
Published on: January 6, 2015
Toll-like receptor 4 deficiency causes pulmonary emphysema
Xuchen Zhang1, Peiying Shan, Ge Jiang
1Section of Pulmonary and Critical Care Medicine, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
The Journal of Clinical Investigation
|October 21, 2006
Summary
Toll-like receptor 4 (TLR4) deficiency in mice leads to emphysema due to increased oxidant generation. Restoring TLR4 function in lung cells prevents lung damage, revealing a protective role for TLR4 in maintaining lung integrity.
Area of Science:
- Pulmonary immunology
- Cellular biology
- Pathology
Background:
- Toll-like receptors (TLRs) are crucial in pathogen response, but their role in the healthy lung is unclear.
- The lung constantly interacts with environmental factors like particulates and oxygen, necessitating mechanisms for maintaining structural integrity.
- Emphysema, characterized by lung elasticity loss and airspace enlargement, often results from chronic insults like cigarette smoke.
Purpose of the Study:
- To investigate the role of Toll-like receptor 4 (TLR4) in maintaining lung structure in an unchallenged environment.
- To elucidate the mechanisms underlying TLR4's function in lung homeostasis and its connection to emphysema development.
Main Methods:
- Utilized Tlr4(-/-) knockout mice to study the effects of TLR4 deficiency on lung architecture.
- Conducted adoptive transfer experiments to assess the requirement of TLR4 in lung structural cells.
- Investigated the role of NADPH oxidase 3 (Nox3) and oxidant generation in Tlr4(-/-) mice.
- Employed chemical NADPH inhibitors and Nox3 siRNA for therapeutic interventions.
Main Results:
- Tlr4(-/-) mice developed emphysema with age, indicating a role for TLR4 in preventing lung degradation.
- TLR4 expression in lung structural cells is essential for maintaining normal lung architecture.
- TLR4 deficiency resulted in increased Nox3 expression, elevated oxidant generation, and enhanced elastolytic activity.
- Inhibition of NADPH oxidase or Nox3 reversed the emphysematous changes in Tlr4(-/-) mice and endothelial cells.
Conclusions:
- TLR4 plays a critical role in maintaining constitutive lung integrity by regulating oxidant generation.
- Dysregulation of TLR4 signaling contributes to the pathogenesis of emphysema.
- Targeting Nox3 and oxidant pathways offers potential therapeutic strategies for emphysema.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...